Introduction Interstitial lung disease (ILD) is a heterogeneous group of diseases characterized
by varying degrees of lung inflammation and/or fibrosis. We investigated biomarkers to …

C–X–C motif chemokine ligand 9 (CXCL9), a candidate biomarker, reflects type 1 (T1)
inflammation pathology. Here, we report the analytical performance and clinical characteristics of …

A 29-year-old man was admitted to our hospital because of fever elevation, dry cough,
malaise, skin eruption, and dyspnea with hypoxemia. His serum levels of surfactant protein (SP)-A …

Objective Inflammatory cytokines generated in visceral fat have been shown to contribute to
the development of insulin resistance. The involvement of pulmonary inflammation in insulin …

A 68-year-old woman presented with cough and dyspnea. Chest x-ray film and computed
tomography revealed atelectasis in the right upper lobe. She had a history of a bladder …

Idiopathic pulmonary fibrosis (IPF) is a chronic, progressive, fatal lung disorder characterized
by aberrant extracellular matrix deposition in the interstitium. Pirfenidone is an antifibrotic …

The paper describes the user interface design of the Group Teleworking System (GTWS),
which is designed to support multiple conference spaces. GTWS is developed as a real time …

Introduction: Idiopathic pulmonary fibrosis (IPF) is a fatal lung disease characterized by
extracellular matrix deposition in the lung interstitium. Pirfenidone is an anti-fibrotic drug to treat …

Background: Interstitial lung diseases (ILD) are characterized by inflammation and/or fibrosis
of the lungs. Patients with idiopathic pulmonary fibrosis (IPF) are unlikely to respond to …

Background: Endocytoscopy system (prototype, BF-Y0005, Olympus Medical Systems Co.,
Tokyo, Japan) is a bronchovideoscope visualizing at a high magnification of 450 times on a …